CClinicalTrials.gg
CompletedNCT05788731PASSyDroitUpdated Mar 29, 2023

Become of Patients From the Permanent Access to Care (PASS) in Cayenne, French Guyana, Suffering From a Chronic Disease (High Blood Pressure - Diabetes) in the Common Law Schemes

An observational study in Access to Health Services, Health Disparity, Minority and Vulnerable Populations and Chronic Disease, sponsored by Centre Hospitalier de Cayenne. Completed at 1 site in French Guiana. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-29.

Sponsored by Centre Hospitalier de Cayenne · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

It is an observational research, conducted at the Cayenne hospital about the future of hypertensive and/or diabetic patients after their follow-up at the Permanent Access to care (PASS). The PASS is a medico-social structure that allows access to medical monitoring and support towards common law. The main objective of the study is to evaluate the use of the common law system by these patients. Then the goal is to study the relationship between integration into the system and socio-demographic, medical characteristics, and understanding of health monitoring. Data will be collected by guided telephone interviews and the review of medical records.

Read the detailed description

The problems of social inequalities in access to care are major public health issues as recalled by the Regional Health Agency (ARS) of French Guiana in the Regional Health Project (PRS). French Guiana has high precariousness indicators with half of its population living below the poverty line. In addition, health indicators are often more degraded in precarious populations. Thus, in French Guiana, there is a higher rate of premature mortality, partly attributable to obesity, sedentary lifestyle, diabetes and hypertension than in mainland France. Despite an increased need for follow-up of chronic pathologies, the precarious population faces many difficulties in accessing care. The Permanent Access to Health Care (PASS) in Cayenne is a medico-social system, created to respond to these problems. The PASS allows access to monitoring of chronic diseases and support towards the common law healthcare system. Although the phenomenon of non-use of care studied in the precarious population of western French Guiana seems primarily attributable to the absence of social security. The main objective is to evaluate the use of the common law system in hypertensive or diabetic patients treated at the PASS in Cayenne. In addition, the investigators want to study the relationship between integration into the system and the socio-demographic, medical characteristics, understanding of health monitoring.

02

Conditions studied

  • Access to Health Services
  • Health Disparity, Minority and Vulnerable Populations
  • Chronic Disease
  • Social Security

Keywords

  • Health care system
  • Vulnerable Populations
  • Chronic Disease
  • social security
  • French Guiana
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 120 is below the median of 210 across 1,359 observational studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Centre Hospitalier de Cayenne is the lead sponsor of 47 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Majeur patients of the PASS of CH de Cayenne with a chronic disease

Inclusion criteria

  • Be 18 years or older
  • Past follow-up by the PASS of the Cayenne hospital for at least one chronic pathology identified as follows: hypertension, diabetes.
  • The discharge and reorientation to general practitioner have happened between 1 month and 1 year prior to this study.

Exclusion criteria

Exclusion Criteria:

  • Patient with a psychiatric condition
  • Refusing the study
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
120 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The proportion of patients integrating the common law system

    It is collected through telephone interviews while inclusions are carried out.

    Time frame: during inclusion

Secondary outcomes

  1. Study the relationship between system integration and socio-demographic, understanding characteristics

    Time frame: during inclusion

  2. Study the relationship between system integration and medical, health follow-up

    Time frame: during inclusion

  3. Proportion of patients resorting to one or more consultations with a general practitioner.

    Time frame: during inclusion

07

Study locations

1 site
  • Centre Hospitalier de Cayenne
    Cayenne, 97306, French Guiana
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05788731
Lead sponsor
Centre Hospitalier de Cayenne
Responsible party
Sponsor
First posted
Mar 29, 2023
Start date
Jan 18, 2023
Primary completion
Feb 28, 2023
Completion
Feb 28, 2023
Last update
Mar 29, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion